Voisin Consulting Life Sciences glossary icon

Health Technology Assessment Bodies (HTABs)

Click a letter to view all its definitions

Regional and national HTA bodies provide recommendations on medicines and other health technologies that can be financed or reimbursed by the healthcare system in a particular Member State or region. In countries where health technology assessment is in place, payers, pricing and reimbursement agencies or HTA bodies rely upon these assessments to:

  • determine reimbursement status;
  • provide information on benefits and harms of new treatments compared to available treatment options;
  • support the price negotiation process.

The assessment criteria used by HTA bodies differ between Member States, in accordance with regional and national legislation.

Other glossary definitions


Safety concern

An important identified risk, an important potential risk, or important missing information.

View definition

Investigational New Drug (IND)

Administering an investigational drug to humans is subject to prior approval from regulatory authorities. Investigational…

View definition